Posted
Healthcare economist Paul Keckley says the upholding of President Obama's healthcare reform bill might mean biotech companies will be less likely to invest in research and development.
01:50
02:31
01:51
03:00
02:09
01:39
01:51
01:23
02:42
01:51
01:27
01:55
03:15
02:05
01:18
02:13
01:08
02:06
01:01
01:12
00:37
01:11
00:41
00:39
02:30
01:16
01:41
02:00
00:58
00:41
01:08
01:35
01:09
00:40
01:33
01:16
00:35
01:08
02:25
01:16
01:19
01:58
01:12
00:35
01:48
02:57
01:36
02:00
01:25
02:44
00:48
01:18
00:45
02:49
02:16